{"id":517454,"date":"2021-07-26T08:33:56","date_gmt":"2021-07-26T12:33:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/"},"modified":"2021-07-26T08:33:56","modified_gmt":"2021-07-26T12:33:56","slug":"oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/","title":{"rendered":"OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">PENNINGTON, N.J.<\/span> and <span class=\"xn-location\">SAN DIEGO<\/span>, <span class=\"xn-chron\">July 26, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0OncoSec Medical Incorporated (NASDAQ:ONCS) (the &#8220;Company&#8221; or &#8220;OncoSec&#8221;) today announced that Interim CEO and Chief Operating Officer, <span class=\"xn-person\">Brian Leuthner<\/span>, and Senior Vice President, Chief Clinical Development Officer, <span class=\"xn-person\">Sandra Aung<\/span>, Ph.D., will participate in a fireside chat at the BTIG Virtual Biotechnology Conference being held Monday, August, 9<sup>th<\/sup>\u00a0\u2013 <span class=\"xn-chron\">Tuesday, August 10<\/span><sup>th<\/sup>, 2021.<\/p>\n<p>\n        <b>BTIG Virtual Biotechnology Conference <br \/><\/b>Date: <span class=\"xn-chron\">Monday, August 9<\/span><sup>th<\/sup>\u00a0\u00a0<br \/>Time: <span class=\"xn-chron\">2:00pm ET<\/span><\/p>\n<p>For those not attending, a replay of the presentation will be available until the end of the conference on the BTIG conference website. Must be a BTIG client to attend and access the replay.\u00a0\u00a0\u00a0 \u00a0<\/p>\n<p>\n        <b>About OncoSec Medical Incorporated<br \/><\/b>OncoSec Medical Incorporated (the &#8220;Company,&#8221; &#8220;OncoSec,&#8221; &#8220;we&#8221; or &#8220;our&#8221;) is a biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body&#8217;s immune system to target and attack cancer.\u00a0 OncoSec&#8217;s lead immunotherapy investigational product candidate \u2013 TAVO\u2122 (tavokinogene telseplasmid) \u2013 enables the intratumoral delivery of DNA-based interleukin-12 (IL-12), a naturally occurring protein with immune-stimulating functions.\u00a0 The technology, which employs electroporation, is designed to produce a controlled, localized expression of IL-12 in the tumor microenvironment, enabling the immune system to target and attack tumors throughout the body.\u00a0 OncoSec has built a deep and diverse clinical pipeline utilizing TAVO\u2122 as a potential treatment for multiple cancer indications either as a monotherapy or in combination with leading checkpoint inhibitors; with the latter potentially enabling OncoSec to address a great unmet medical need in oncology: anti-PD-1 non-responders. \u00a0Results from recently completed clinical studies of TAVO\u2122 have demonstrated a local immune response, and subsequently, a systemic effect as either a monotherapy or combination treatment approach along with an acceptable safety profile, warranting further development. \u00a0In addition to TAVO\u2122, OncoSec is identifying and developing new DNA-encoded therapeutic candidates and tumor indications for use with its new Visceral Lesion Applicator (VLA), to target deep visceral lesions, such as liver, lung or pancreatic lesions.\u00a0 For more information, please visit\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3238545-1&amp;h=3566589485&amp;u=http%3A%2F%2Fwww.oncosec.com%2F&amp;a=www.oncosec.com\" rel=\"nofollow noopener\">www.oncosec.com<\/a>.<\/p>\n<p>TAVO\u2122 is a trademark of OncoSec Medical Incorporated.<\/p>\n<p>\n        <b>Company Contact<br \/><\/b><br \/>\n        <b>Investor Contact<br \/><\/b><br \/>\n        <span class=\"xn-person\">Mike Moyer<\/span><br \/>\n        <br \/>LifeSci Advisors<br \/>+1-617-308-4306<br \/><a target=\"_blank\" href=\"mailto:mmoyer@lifesciadvisors.com\" rel=\"nofollow noopener\">mmoyer@lifesciadvisors.com<\/a><\/p>\n<p>\n        <b>Media Contact<br \/><\/b><br \/>\n        <span class=\"xn-person\">Patrick Bursey<\/span><br \/>\n        <br \/>LifeSci Communications<br \/>+1-646-970-4688<br \/><a target=\"_blank\" href=\"mailto:pbursey@lifescicomms.com\" rel=\"nofollow noopener\">pbursey@lifescicomms.com<\/a>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1526\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.jpg\" title=\"OncoSec Medical Incorporated logo (PRNewsfoto\/OncoSec Medical Incorporated)\" alt=\"OncoSec Medical Incorporated logo (PRNewsfoto\/OncoSec Medical Incorporated)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA53853&amp;sd=2021-07-26\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference-301340818.html\">https:\/\/www.prnewswire.com\/news-releases\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference-301340818.html<\/a><\/p>\n<p>SOURCE  OncoSec Medical Incorporated<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA53853&amp;Transmission_Id=202107260830PR_NEWS_USPR_____LA53853&amp;DateId=20210726\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire PENNINGTON, N.J. and SAN DIEGO, July 26, 2021 \/PRNewswire\/ &#8212;\u00a0OncoSec Medical Incorporated (NASDAQ:ONCS) (the &#8220;Company&#8221; or &#8220;OncoSec&#8221;) today announced that Interim CEO and Chief Operating Officer, Brian Leuthner, and Senior Vice President, Chief Clinical Development Officer, Sandra Aung, Ph.D., will participate in a fireside chat at the BTIG Virtual Biotechnology Conference being held Monday, August, 9th\u00a0\u2013 Tuesday, August 10th, 2021. BTIG Virtual Biotechnology Conference Date: Monday, August 9th\u00a0\u00a0Time: 2:00pm ET For those not attending, a replay of the presentation will be available until the end of the conference on the BTIG conference website. Must be a BTIG client to attend and access the replay.\u00a0\u00a0\u00a0 \u00a0 About OncoSec Medical IncorporatedOncoSec Medical Incorporated (the &#8220;Company,&#8221; &#8220;OncoSec,&#8221; &#8220;we&#8221; or &#8220;our&#8221;) is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-517454","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire PENNINGTON, N.J. and SAN DIEGO, July 26, 2021 \/PRNewswire\/ &#8212;\u00a0OncoSec Medical Incorporated (NASDAQ:ONCS) (the &#8220;Company&#8221; or &#8220;OncoSec&#8221;) today announced that Interim CEO and Chief Operating Officer, Brian Leuthner, and Senior Vice President, Chief Clinical Development Officer, Sandra Aung, Ph.D., will participate in a fireside chat at the BTIG Virtual Biotechnology Conference being held Monday, August, 9th\u00a0\u2013 Tuesday, August 10th, 2021. BTIG Virtual Biotechnology Conference Date: Monday, August 9th\u00a0\u00a0Time: 2:00pm ET For those not attending, a replay of the presentation will be available until the end of the conference on the BTIG conference website. Must be a BTIG client to attend and access the replay.\u00a0\u00a0\u00a0 \u00a0 About OncoSec Medical IncorporatedOncoSec Medical Incorporated (the &#8220;Company,&#8221; &#8220;OncoSec,&#8221; &#8220;we&#8221; or &#8220;our&#8221;) is &hellip; Continue reading &quot;OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-26T12:33:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference\",\"datePublished\":\"2021-07-26T12:33:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\\\/\"},\"wordCount\":387,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/686236\\\/oncosec_logo_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\\\/\",\"name\":\"OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/686236\\\/oncosec_logo_Logo.jpg\",\"datePublished\":\"2021-07-26T12:33:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/686236\\\/oncosec_logo_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/686236\\\/oncosec_logo_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/","og_locale":"en_US","og_type":"article","og_title":"OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference - Market Newsdesk","og_description":"PR Newswire PENNINGTON, N.J. and SAN DIEGO, July 26, 2021 \/PRNewswire\/ &#8212;\u00a0OncoSec Medical Incorporated (NASDAQ:ONCS) (the &#8220;Company&#8221; or &#8220;OncoSec&#8221;) today announced that Interim CEO and Chief Operating Officer, Brian Leuthner, and Senior Vice President, Chief Clinical Development Officer, Sandra Aung, Ph.D., will participate in a fireside chat at the BTIG Virtual Biotechnology Conference being held Monday, August, 9th\u00a0\u2013 Tuesday, August 10th, 2021. BTIG Virtual Biotechnology Conference Date: Monday, August 9th\u00a0\u00a0Time: 2:00pm ET For those not attending, a replay of the presentation will be available until the end of the conference on the BTIG conference website. Must be a BTIG client to attend and access the replay.\u00a0\u00a0\u00a0 \u00a0 About OncoSec Medical IncorporatedOncoSec Medical Incorporated (the &#8220;Company,&#8221; &#8220;OncoSec,&#8221; &#8220;we&#8221; or &#8220;our&#8221;) is &hellip; Continue reading \"OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-26T12:33:56+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference","datePublished":"2021-07-26T12:33:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/"},"wordCount":387,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/","name":"OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.jpg","datePublished":"2021-07-26T12:33:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-participate-in-fireside-chat-at-btig-virtual-biotechnology-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=517454"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517454\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=517454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=517454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=517454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}